Navigation Links
NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs

CHARLESTON, S.C., Oct. 19 /PRNewswire/ -- The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

NASCSA will manage the solicitation, review and funding of grant proposals. State government agencies or departments will be selected based on an independent review by the NASCSA Special Projects Committee, which consists of association members with expertise in the fields of prescription drug abuse and diversion and prescription drug monitoring programs. Purdue Pharma will have no input into the final selection process.  

"State budgets are shrinking, but the abuse and diversion of prescription drug problem is a growing concern, said Kathy Keough, NASCSA Executive Director. "Purdue Pharma's funding of state prescription drug monitoring programs will help keep these medications out of the wrong hands while ensuring legitimate patients have access to the medications they need."

The grant monies are scheduled to be distributed by NASCSA to various state government departments or agencies with the ability to accept private funding expressly for their state prescription monitoring program by the end of 2011.

"Since 2001, Purdue Pharma has been working to support the implementation of appropriately-designed prescription monitoring programs as one way to help reduce abuse and diversion of prescription medications," said Alan Must, vice president of state government and legislative affairs at Purdue Pharma. "Reducing the abuse of prescription medications will take the combined and coordinated efforts of healthcare professionals, law enforcement, government agencies and local communities. NASCSA is an organization that is uniquely qualified to address the issues of prescription drug abuse from a broad inclusive perspective and we are delighted to provide this funding for this initiative."

The National Association of State Controlled Substances Authorities is a 501(C)(3) non-profit educational organization whose primary purpose is to provide a continuing mechanism through which state and federal agencies can work to increase the effectiveness and efficiency of efforts to prevent and control drug diversion and abuse. NASCSA can be found at

Purdue Pharma L.P. is a privately-held pharmaceutical company known for pioneering research on persistent pain. Headquartered in Stamford, CT, Purdue is engaged in the research, development, production, and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue Pharma can be found at Media Contacts:Kathy KeoughNASCSA617-347-1455kathykeough@nascsa.orgLibby HolmanPurdue Pharma

SOURCE Purdue Pharma L.P.; National Association of State Controlled Substances Authorities
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
2. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
3. ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™
4. Watsons Generic Version of Lotrel ® Receives FDA Approval
5. EntreMed Receives Notice of NASDAQ Compliance
6. Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®
7. Greenways PrimeSUITE Receives ONC-ATCB 2011/2012 Certification
8. Talecris Biotherapeutics Receives FDA Approval for Gamunex®-C
9. Sunridge Receives Reorder on $4 Million Indian Contract
10. Pharmalink AB Receives US Orphan Drug Designation for Nefecon(R) (PL-56)
11. Actavis Receives Approval of Losartan Potassium Tablets, USP in the U.S.
Post Your Comments:
(Date:11/30/2015)... 2015 --> --> ... Market by Product (Soft Tissue, All Tissue, Dental Welding Lasers), ... and Geography - Global Forecast to 2020", published by MarketsandMarkets, ... a CAGR of 5.2% during the forecast period from 2015 ... and 62 Figures spread through 167 P ages and ...
(Date:11/30/2015)... INDIANAPOLIS , Nov. 30, 2015  PTS Diagnostics, ... as CardioChek ® analyzers, A1CNow ® systems, ... of a family of patents that will propel the ... and Europe . The ... cameras, such as those on smartphones and tablets, and ...
(Date:11/30/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ), ... oral drug delivery systems, announced today it has signed ... Hefei Tianhui Incubator of Technologies Co., Ltd. ("HTIT") for exclusive ... China , Hong Kong ... agreements were signed at the Israel Knesset (Parliament). ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... the United States to access life-saving information provided directly from top experts ... consist of three individual conferences in three major cities: Houston, San Francisco, and ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its annual fundraising campaign to raise funds for its research, education, support, and ... of the organization’s annual funding. , The Mesothelioma Applied Research Foundation, which also ...
(Date:11/30/2015)... Wilmington, DE (PRWEB) , ... November 30, 2015 ... ... a guest lecturer at a University of Delaware Accounting and Management of Information ... accounting software solutions for mid-market businesses. Sommer will speak at before student in ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Progressive Dental Institute ... January 29 and 30, 2016. The course welcomes dental professionals and members of ... learn how to better succeed in the modern dental marketplace. The course combines ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
Breaking Medicine News(10 mins):